Obexelimab in IgG4-Related Disease: INDIGO Trial Dr. Henrique Dalmolin reports on abstract OP018 from EULAR 2026. htt | RheumNow

Obexelimab in IgG4-Related Disease: INDIGO Trial Dr. Henrique Dalmolin reports on abstract OP018 from EULAR 2026. https://t.co/Wid9ZzESae https://t.co/Qo4y8ebkOn

Links:

Obexelimab in IgG4-Related Disease: INDIGO Trial | RheumNow https://buff.ly/6TSOWQD

Jun-30-2026

×